Light meets precision with a click
A New Light in Cancer Treatment
At SCALPEL, we are pioneering a breakthrough approach to cancer therapy — combining the precision of light-based technology with the power of immunotherapy. Our innovative method uses light-activated click chemistry to tag and destroy cancer cells with exceptional accuracy, while helping the body prevent future recurrence.
“For so long we have fought cancer with the same set of tools, doing our best to remove as much of it as we can. Yet the toughest challenge remains: the cells that slip through the cracks. With SCALPEL, we are taking a radically new approach using light and precision to not only destroy tumours, but to seek out and tag those elusive surviving cells, so the immune system can make sure that none are left behind. Precision, light and immunity are rewriting the rules of cancer therapy.”
Oslo Universitetssykehus HF, SCALPEL Project Coordinator
Start
01 March 2025
01 March 2025
Duration
54 Months
54 Months
Team
6 Partners from 5 Countries
6 Partners from 5 Countries
Budget
4.5 Million €
4.5 Million €